Dupixent Lawyers of HLF A Division of The Hurwitz Law Firm PC · Lymphoma Attorneys

Nebraska Dupixent Lawsuit Attorneys for CTCL Cancer Claims

NEBRASKA DUPIXENT LAWYERS: Omaha, Lincoln, Bellevue, and Grand Island text on NE state flag adorned with a syringe and medical jar depicted on a dark blue field near the official seal in gold

Need a Nebraska Dupixent lawsuit attorney?

Omaha · Lincoln · Bellevue · Grand Island

Call Now: (888) 510-9256

Hotline Open 24 Hours

Nebraska Dupixent lawsuits claim anti-inflammatory drug-makers failed to protect patients from cancer. The medication has been blamed for many eczema and asthma patients developing cutaneous T-cell lymphoma. (See our NE Dupixent News)

As such, our Nebraska Dupixent lawyers are filing CTCL cancer lawsuits for inflammation drug victims.


Nebraska Dupixent Lawyers Advocate for T-Cell Cancer Victims

Our team of Nebraska Dupixent attorneys has represented thousands of victims of dangerous pharmaceutical products. In doing so, we have recovered millions of dollars in settlement funds on their behalf.

However, we only pursue compensation from Dupixent manufacturers and affiliates, and do not file claims against our clients’ doctors or hospitals.


No Legal Fee Unless You Obtain a Settlement

While compensation may be available to qualified Dupixent claimants, victims are urged to act promptly. The #1 claim Nebraska Dupixent victims can make for cancer compensation is one filed within the Statute of Limitations. Follow this link for our latest information on Dupixent multi-district litigation (MDL).

Our Nebraska Dupixent lawyers are available to review claims now. We offer a free case evaluation to confirm use of Dupixent and diagnosis of a related cancer. Further, we never charge a legal fee unless a financial recovery is obtained for our client.

Get your Nebraska Dupixent lawsuit review.



Nebraska Dupixent Lawyers File Lymphoma Lawsuits Statewide

8th Circuit Dupixent Claims in Nebraska

Nebraska is part of the Eighth Circuit of the federal court system, and Dupixent lawsuits can be filed at its local U.S. District Court. Eczema/Asthma medication appeals are heard by the 8th Circuit Court of Appeals.

However, federal Dupixent lawsuits filed in Nebraska may be transferred to a centralized jurisdiction pursuant to a lymphoma cancer Multi-District Litigation (MDL) Transfer Order. (Please follow this link for our additional information on 8th Circuit Dupixent compensation.)


File Your 8th Circuit Dupixent Settlement Claim Here text on depiction of Eighth Circuit court with syringe arm injection and high value cash backdrop.
File your Nebraska Dupixent lawsuit in 8th Circuit federal district court.

Nebraska State Dupixent Claims

Nebraska Dupixent lawyers can also file skin cancer lawsuits in the State’s county courts (NE Courts Website). The State’s procedural law for lymphoma claims is governed by the:

  • Nebraska Court Rules of Pleading in Civil Cases
  • Nebraska Court Rules of Discovery in Civil Cases
  • Uniform District Court Rules of Practice and Procedure

The State of Nebraska follows a modified comparative negligence rule. Accordingly, a Nebraska Dupixent lawyer can recover damages for wrongful conduct by Regeneron Pharmaceuticals and Sanofi provided the plaintiff is less than 50% at fault. However, the inflammation patient’s recovery may be reduced by their own degree of fault (if any).

For FAQs about the ongoing T-cell lymphoma litigation, please see our Dupixent lawyers homepage.

Contact our Nebraska Dupixent lawyers today.